News

Investors looking for stocks in the Insurance - Property and Casualty sector might want to consider either RenaissanceRe (RNR) or Kinsale Capital Group, Inc. (KNSL). But which of these two stocks

Investors interested in Mining - Miscellaneous stocks are likely familiar with Nexa Resources S.A. (NEXA) and Anglo American (NGLOY). But which of these two companies is the best option for those

Investors interested in Business - Information Services stocks are likely familiar with FactSet Research (FDS) and Verisk Analytics (VRSK). But which of these two companies is the best option for

Investors with an interest in Medical - Drugs stocks have likely encountered both Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two

Investors interested in Automotive - Domestic stocks are likely familiar with Blue Bird (BLBD) and Tesla (TSLA). But which of these two stocks presents investors with the better value opportunity

Investors interested in stocks from the Insurance - Multi line sector have probably already heard of Aegon NV (AEG) and Prudential (PUK). But which of these two stocks presents investors with the

Geopolitical tensions in the Middle East have escalated sharply over the past week, with the United States and Israel engaged in an intensifying conflict with Iran that has disrupted production and

NeuroPace, Inc. NPCE enters 2026 after posting $100 million in 2025 revenue, up 25% year over year. The business is also moving toward a cleaner mix, with the core RNS System taking center stage as

NeuroPace, Inc. NPCE is building a procedure-driven growth story around its RNS System, a brain-responsive implant designed to reduce seizures in adults with drug-resistant focal epilepsy. The

GSK plc GSK signed a license agreement with Italy-based Alfasigma. Per the terms of the agreement, Alfasigma has acquired exclusive global rights from GSK to develop and market linerixibat, an

Figma FIG stock is trading at a premium, with a forward 12-month Price/Sales of 9.46X compared with the Zacks Internet - Software industry’s 4.03X. The overvaluation is further established by the

J&J JNJ announced that the European Commission has approved its precision therapy, Akeega (niraparib and abiraterone acetate dual action tablet), for expanded use in prostate cancer. The regulatory

Hewlett Packard Enterprise HPE reported better-than-expected results for first-quarter fiscal 2026. The company’s non-GAAP earnings of 65 cents per share beat the Zacks Consensus Estimate by 10.2%

Shares of Xenon Pharmaceuticals XENE surged 49.6% yesterday after the company announced positive top-line data from the phase III X-TOLE2 study, which evaluated its lead pipeline candidate

NeuroPace, Inc. NPCE is moving beyond a device-only story and leaning into software and workflow tools that aim to expand clinician capacity. The company is also pursuing an indication expansion

Booz Allen Hamilton’s BAH top line is gaining from long-term government contracts, providing steady revenues and offsetting market volatility. The company’s strong strategies improve operational

VAALCO Energy EGY, an independent exploration and production company, has recently finished drilling the ET-14P exploration well at the Etame field, which was part of its Phase Three drilling

Advance Auto Parts, Inc. AAP, is a leading automotive parts provider in North America, serving both the do-it-yourself or DIY and professional installers.

While AAP expects some hiccups due to

3D Systems DDD reported a fourth-quarter 2025 non-GAAP loss of 13 cents per share, narrower than the reported loss of 19 cents per share in the year-ago quarter. The Zacks Consensus Estimate was

Understanding “Picks and Shovels” Investments

During the California Gold Rush of the mid-1800s, the term “picks and shovels” became prominent. In the case of the Gold Rush, picks-and-shovel plays

Editas Medicine EDIT reported a loss of 6 cents per share in the fourth quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of 27 cents. The company had incurred a loss of 55 cents

Kronos Worldwide, Inc. KRO reported a fourth-quarter 2025 net loss of $82.8 million or 72 cents per share. This compares unfavorably to a loss of $13.2 million, or 12 cents per share, in the

With assurances that the war in Iran will be a short-lived “excursion,” oil prices yesterday pulled back from their highest levels in almost 20 years — the first drop in oil prices since the U.S

BASF SE BASFY has signed a definitive agreement to divest hydrosulfite-related assets to Silox. The transaction includes intellectual property rights, special containers, selected production